![Won-Ki Cho](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Won-Ki Cho
Président chez CHOA PHARMACEUTICAL CO., LTD.
Fortune : 4 M $ au 31/05/2024
Postes actifs de Won-Ki Cho
Sociétés | Poste | Début | Fin |
---|---|---|---|
CHOA PHARMACEUTICAL CO., LTD. | Président | 01/01/1988 | - |
Medipharm
![]() Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Président | - | - |
Historique de carrière de Won-Ki Cho
Formation de Won-Ki Cho
Pusan National University | Undergraduate Degree |
Pukyong National University | Doctorate Degree |
Kyungpook National University | Undergraduate Degree |
Statistiques
Internationale
Corée du Sud | 6 |
Opérationnelle
Chairman | 2 |
Undergraduate Degree | 2 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 4 |
Health Technology | 2 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Medipharm
![]() Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Bourse
- Insiders
- Won-Ki Cho
- Expérience